ICD-9-CM 272.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 272.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma triglycerides, endogenously synthesized and contained predominantly in very-low-density lipoproteins (pre-beta lipoproteins). In contrast, the plasma cholesterol and phospholipids usually remain within normal limits
Characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in vldl; considered to be an autosomal dominant trait